Processa Pharmaceuticals, Inc. Accumulated Amortization of Other Deferred Costs
Processa Pharmaceuticals, Inc. (PCSA) had Accumulated Amortization of Other Deferred Costs of $272.51 thousand as of 2014-12-31, per its 10-K filed 2017-06-19.
Discontinued › Notes
us-gaap:AccumulatedAmortizationOfOtherDeferredCosts · last filed 2017-06-19
- 2014-12-31: Accumulated Amortization of Other Deferred Costs $272.51K.
- 2013-12-31: Accumulated Amortization of Other Deferred Costs $42.38K.
| Period end | Accumulated Amortization of Other Deferred Costs |
|---|---|
| 2014-12-31 | $272.51K 10-K · filed 2017-06-19 |
| 2013-12-31 | $42.38K 10-K · filed 2015-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |